Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

The Kolling welcomes Australia’s leading genomics provider to the institute

The Kolling welcomes Australia’s leading genomics provider to the institute

Researchers within the Kolling Institute will shortly have the chance to strengthen their genomics c..... Read more

Category: Research Excellence, World-leading technology

September 2025 Kolling NEWS

September 2025 Kolling NEWS

Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert tea..... Read more

Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, New Treatment, Research Excellence

Game-changing blood test to detect bowel cancer

Game-changing blood test to detect bowel cancer

Bowel cancer is the third most common type of cancer in Australia and treating it is both costl..... Read more

Category: Research Excellence